BRIEF published on 06/30/2025 at 22:35, 11 months 20 days ago Biophytis Delays Publication of 2024 Annual Financial Statements Biophytis Biotechnology Drug Development Annual Accounts Financial Delay
REGULATED PRESS RELEASE published on 06/30/2025 at 22:30, 11 months 20 days ago Information on the Annual Financial Statements Biophytis delays publishing of 2024 annual accounts, aiming for release by July 7. The company focuses on treatments for age-related diseases Financial Statements Biophytis Age-related Diseases 2024 Annual Accounts Clinical-stage Biotechnology Company
PRESS RELEASE published on 06/30/2025 at 22:29, 11 months 20 days ago Information on the Annual Financial Statements Biophytis SA delays publication of 2024 annual accounts, aiming to release by July 7. The clinical-stage biotech company focuses on age-related disease treatments Biotechnology Company Clinical-stage Biophytis SA Age-related Diseases 2024 Annual Accounts
BRIEF published on 06/19/2025 at 23:05, 1 year ago Biophytis Temporarily Suspends Share Trading Biophytis Regulatory Compliance Financial Report Euronext Growth Share Suspension
REGULATED PRESS RELEASE published on 06/19/2025 at 23:00, 1 year ago Biophytis announces the temporary suspension of the trading of its shares Biophytis announces temporary suspension of trading shares on Euronext due to delayed financial report. Expected to resume after report publication. Company info included Biophytis Euronext Trading Financial Report Suspension
PRESS RELEASE published on 06/19/2025 at 22:59, 1 year ago Biophytis announces the temporary suspension of the trading of its shares Biophytis announces temporary suspension of trading of its shares by Euronext due to non-publication of annual financial report for 2024, expected to resume after report publication Biophytis Shares Euronext Trading Suspension
BRIEF published on 06/04/2025 at 07:05, 1 year ago Biophytis to Attend BIO International Convention in Boston Biophytis Biotechnology Partnerships BIO101 Convention
REGULATED PRESS RELEASE published on 06/04/2025 at 07:00, 1 year ago Biophytis announces its participation in the BIO International Convention from June 16 to 19 Biophytis announces participation in BIO International Convention from June 16 to 19, 2025 in Boston, USA. Focus on drug candidate BIO101 and potential partnerships Biophytis Biotechnology Partnerships BIO International Convention Drug Candidate
BRIEF published on 05/30/2025 at 22:05, 1 year ago Biophytis Delays 2024 Annual Financial Report Publication Financial Statements Biophytis Shareholder Meeting Age-related Diseases Audit Delay
REGULATED PRESS RELEASE published on 05/30/2025 at 22:00, 1 year ago Information on the Annual Financial Statements Biophytis postpones the publication of its 2024 annual financial statements due to technical complications in the audit process. The Company aims to complete the audit by the end of June 2025 Biophytis Audit Postponement 2024 Annual Financial Statements Technical Complications
Published on 06/20/2026 at 01:00, 1 day 19 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 20 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days 16 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 19 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 19 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 23 hours 14 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 14 hours ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 2 days ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 2 days 1 hour ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 2 days 1 hour ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 1 hour ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 3 days 2 hours ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 3 days 2 hours ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 3 days 3 hours ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026
